Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
AMWL 
American Well Corp (AMWL)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/12/2025: AMWL (1-star) is a SELL. SELL since 4 days. Profits (-12.38%). Updated daily EoD!
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
9 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $9.5
1 Year Target Price $9.5
| 1 | Strong Buy |
| 0 | Buy |
| 8 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -69.71% | Avg. Invested days 23 | Today’s Advisory SELL |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/12/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 115.81M USD | Price to earnings Ratio - | 1Y Target Price 9.5 |
Price to earnings Ratio - | 1Y Target Price 9.5 | ||
Volume (30-day avg) 9 | Beta 1.28 | 52 Weeks Range 6.09 - 12.95 | Updated Date 08/12/2025 |
52 Weeks Range 6.09 - 12.95 | Updated Date 08/12/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -8.03 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-07-29 | When Before Market | Estimate -1.1105 | Actual -0.7231 |
Profitability
Profit Margin -46.16% | Operating Margin (TTM) -28.74% |
Management Effectiveness
Return on Assets (TTM) -17.93% | Return on Equity (TTM) -37.62% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value -96872508 | Price to Sales(TTM) 0.43 |
Enterprise Value -96872508 | Price to Sales(TTM) 0.43 | ||
Enterprise Value to Revenue 0.73 | Enterprise Value to EBITDA -0.82 | Shares Outstanding 14504800 | Shares Floating 12333898 |
Shares Outstanding 14504800 | Shares Floating 12333898 | ||
Percent Insiders 5.19 | Percent Institutions 45.88 |
Upturn AI SWOT
American Well Corp
Company Overview
History and Background
American Well Corp, also known as Amwell, was founded in 2006 by brothers Ido and Roy Schoenberg. Initially focused on providing telehealth services directly to consumers, the company has evolved into a platform connecting healthcare providers, payers, and patients. Amwell went public in September 2020.
Core Business Areas
- Amwell Platform: Provides a comprehensive telehealth platform enabling various virtual care programs, including urgent care, chronic condition management, and behavioral health.
- Amwell Medical Group: Employs physicians and other healthcare professionals who deliver telehealth services directly to patients via the Amwell platform.
- Converge: A fully integrated digital health platform designed to streamline healthcare delivery and improve patient outcomes.
Leadership and Structure
Amwell is led by CEO Ido Schoenberg. The company has a typical corporate structure with executive leadership overseeing various departments such as technology, sales, and marketing.
Top Products and Market Share
Key Offerings
- Amwell Platform: Flagship telehealth platform. Includes secure video conferencing, remote monitoring, and data analytics. Competitors include Teladoc Health, MDLive, and Doctor On Demand. Revenue associated with the platform is the majority of Amwell's revenue.
- Amwell Medical Group: Employs doctors and other healthcare professionals, providing various telehealth care services. Competitors include Teladoc, and various in-person medical practices.
- Converge: Fully integrated digital health platform designed to streamline healthcare delivery and improve patient outcomes. Competitors include Oracle Cerner, Epic Systems.
Market Dynamics
Industry Overview
The telehealth industry is experiencing significant growth, driven by increasing demand for remote healthcare services, technological advancements, and favorable regulatory changes. However, it faces challenges related to reimbursement, data privacy, and integration with existing healthcare systems.
Positioning
Amwell is positioned as a comprehensive telehealth platform provider, differentiating itself through its enterprise-grade platform and focus on partnering with large healthcare systems and payers. Its competitive advantage lies in its integrated platform, diverse service offerings, and established relationships.
Total Addressable Market (TAM)
The global telehealth market is projected to reach hundreds of billions of dollars. Amwell is positioned to capture a significant share of this market by providing a full set of telehealth services.
Upturn SWOT Analysis
Strengths
- Comprehensive telehealth platform
- Established relationships with healthcare systems and payers
- Diverse service offerings
- Brand recognition
- Scalable technology infrastructure
Weaknesses
- Historical lack of profitability
- High operating expenses
- Dependence on key partnerships
- Intense competition
- Platform reliability issues
Opportunities
- Expanding telehealth adoption
- New reimbursement models
- Partnerships with digital health companies
- International expansion
- Integration with wearable devices
Threats
- Increased competition
- Regulatory changes
- Data security breaches
- Economic downturn
- Reimbursement cuts
Competitors and Market Share
Key Competitors
- TDOC
- CVS
- AMZN
Competitive Landscape
Amwell competes with Teladoc Health, MDLive, Doctor On Demand, and other telehealth providers. Its competitive advantage lies in its integrated platform and partnerships with healthcare systems. However, it faces challenges related to profitability and competition.
Major Acquisitions
SilverCloud Health
- Year: 2021
- Acquisition Price (USD millions): 250
- Strategic Rationale: Expanded Amwell's behavioral health capabilities and broadened its platform offerings.
Growth Trajectory and Initiatives
Historical Growth: Amwell has experienced revenue growth in recent years, driven by increased demand for telehealth services. However, profitability has been a challenge.
Future Projections: Analyst projections suggest continued revenue growth for Amwell, but profitability remains uncertain. Projections depend on factors such as market adoption, competition, and reimbursement changes.
Recent Initiatives: Recent initiatives include expanding its platform capabilities, forming strategic partnerships, and focusing on improving the patient experience.
Summary
Amwell is a comprehensive telehealth platform provider with a wide range of services and established relationships. While it experiences revenue growth and partnerships are working well for them, profitability remains a significant challenge due to high operating expenses and intense competition. Amwell needs to focus on achieving profitability and managing competition by further developing the platform and expanding its service to make sure that the platform can work well for them.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Market Research Reports
- Analyst Estimates
- Company Website
- Industry News Sources
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share data is approximate and may vary. Financial data may be outdated and should be verified with the company's latest filings. This analysis is based on publicly available information and does not guarantee future performance.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About American Well Corp
Exchange NYSE | Headquaters Boston, MA, United States | ||
IPO Launch date 2020-09-17 | Chairman & CEO Dr. Ido Schoenberg M.D. | ||
Sector Healthcare | Industry Health Information Services | Full time employees 877 | Website https://business.amwell.com |
Full time employees 877 | Website https://business.amwell.com | ||
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as offers specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members. It also provides Carepoint devices, which transforms proprietary carts, peripherals, tablets, and TVs into digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.